SCHEMBL3580905

SCHEMBL3580905

CC(C)(OC(=O)NCCCC[CH]COCc1ccccc1)C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.41
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 2/20 0.39
KEAP1 Q14145 2/20 0.38
NFE2L2 Q16236 2/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
IDO1 P14902 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GHSR Q92847 1/20 0.37
POLB P06746 2/20 0.36
CTSS P25774 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
SYK P43405 1/20 0.36
PPARA Q07869 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3594233 0.98 HTT (0.41) TGM2HTTLMNASMN1; SMN2MAPT
SCHEMBL3586429 0.92 SMN1; SMN2 (0.41) TGM2HTTLMNASMN1; SMN2MAPT
SCHEMBL3585846 0.87 POLB (0.41) LMNASMN1; SMN2MAPTNPSR1IDO1
SCHEMBL3590061 0.75 SCN9A (0.38) SMN1; SMN2MAOAMAOB
SCHEMBL27928158 0.73 RIPK1 (0.50) LMNASMN1; SMN2MAPTL3MBTL1
SCHEMBL3584000 0.73 CYP2C9 (0.42) LMNASMN1; SMN2MAPTIDO1L3MBTL1
SCHEMBL20196937 0.72 L3MBTL1 (0.58) LMNASMN1; SMN2MAPTNPSR1IDO1
SCHEMBL13622021 0.71 IDO1 (0.56) HTTLMNASMN1; SMN2MAPTNPSR1
SCHEMBL21106167 0.70 L3MBTL1 (0.56) LMNASMN1; SMN2MAPTNPSR1IDO1
SCHEMBL1568590 0.70 IDO1 (0.52) LMNASMN1; SMN2MAPTNPSR1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 Wurster, Siegfried (FI) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048549-A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 SSTR1, SSTR4, SSTR3 TGM2 4102/4885HTT 1383/4885LMNA 4415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.